Join TriSalus Life Sciences for a virtual key opinion leader (KOL) event featuring Nicole Lamparello, MD (Weill Cornell Medicine, New York-Presbyterian Hospital) and Francis Kang, MD (University Radiology Group, Rutgers Robert Wood Johnson University Hospital), who will join company management to discuss the unmet need and current treatment landscape for uterine fibroids.

The event will provide an overview of the TriNav Infusion System whose Pressure-Enabled Drug Delivery™ (PEDD™) approach helps to precisely target the tumor and facilitates deeper therapy penetration while protecting against non-target embolization. The Company will also review the Uterine Artery Embolization (UAE) market landscape and opportunity for TriNav.

A live question and answer session will follow the formal presentations.